Global Drug Discovery Services Market Growth Drivers Research 2022

The drug discovery services market was valued at USD 8.32 billion in 2017 and expected to grow at a CAGR of 11.6% to reach USD 14.40 billion in 2022. The major factors driving the growth of this market are increasing research and development expenditure, inclination of major pharmaceutical companies towards outsourcing to avoid hurdles, and increasing demand for outsourcing of analytical testing and clinical trial services.

Click   Here   for   Complete   Report   on   Drug    Discovery   Services    Market   spread  across   168 Pages, Profiling 13 Companies and Supported with 92 Tables and 39 Figures at http://www.rnrmarketresearch.com/drug-discovery-services-market-by-process-target-selection-hit-to-lead-identification-lead-optimization-type-medicinal-chemistry-biology-services-dmpk-drug-type-small-molecules-biologics-therapeutic-ar-st-to-2022-market-report.html .

On the basis of process, the market is classified into target selection, target validation, hit-to-lead identification, lead optimization, and candidate validation. The hit-to-lead identification segment is expected to register the highest growth rate during the forecast period.

Introduction

1 Objective of the Study

2 Market Definition

3 Market Scope

4 Markets Covered

5 Years Considered in the Study

6 Currency

7 Limitations

8 Stakeholders

By type, the drug discovery services market is segmented into medicinal chemistry, biology services, and drug metabolism and pharmacokinetics (DMPK). The medicinal chemistry segment is expected to register the highest growth rate during the forecast period. Increasing R&D expenditure, growing number of drug discovery and developmental activities, and increasing inclination of pharmaceutical companies towards outsourcing are among the major factors driving the growth of the medicinal chemistry segment.

Click Here for Sample Papers of  Drug   Discovery  Services   Market  with Top Trends and Company Profile at http://www.rnrmarketresearch.com/contacts/request-sample?rname=1232307 .

Geographically, the drug discovery services market is dominated by North America, followed by Europe, Asia Pacific, and the Rest of the World (RoW).North America is expected to command the largest share of the drug discovery services market. The large share of this segment can be attributed to the presence of leading CROs and pharmaceutical companies in this region.

Drug Discovery Services Market, By Therapeutic Area

1 Introduction

2 Oncology

3 Neurology

4 Cardiovascular Diseases

5 Respiratory Diseases

6 Diabetes

7 Other Therapeutic Areas

Click Now for More Details on “Drug Discovery Services Market by Process (Target Selection, Hit-to-Lead Identification, Lead Optimization), Type (Medicinal Chemistry, Biology Services, DMPK), Drug Type (Small Molecules, Biologics), Therapeutic Areas (Oncology, Neurology) – Forecast to 2022”report at http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=1232307 .

The primary interviews conducted for this report can be categorized as follows:

By Company Type – Tier 1 – 40%; Tier 2 – 30% and Tier 3 – 30%

By Designation – C-level – 62%, Director Level – 21%, Others – 17%

By Region – North America –50%, Europe – 20%, Asia Pacific– 20% , RoW- 10%

Key players operating in the drug discovery services market include Thermo Fisher Scientific (US), Albany Molecular Research Inc. (AMRI) (US), Charles River Laboratories (US), Evotec (Germany), Domainex (UK), GenScript (US), Covance (US), Selcia (UK), Viva Biotech (China), WuXi AppTec (China), SRI International (US), Pharmaceutical Product Development, LLC (PPD) (US), GVK Biosciences (India), Jubilant Biosys (India), GE Healthcare (US), Merck (Germany), Lonza (Switzerland), Piramal Enterprises (India), Advinus Therapeutics (India), Promega Corporation (US), Syngene International (India), Aurigene (India), Agilent Technologies (US), Ubiquigent (UK), and ChemBridge Corporation (US).

List of Tables

1 Total Global Pharmaceutical R&D Spending, 2012 to 2022 (USD Billion)
2 R&D Spending, Phrma Member-Companies (USD Billion)
3 Activities Outsourced in the Pharmaceutical Industry (2014 vs 2015)
4 Research Projects Funded By Irdirc Bodies
5 Average Cost of Drugs Approved By Year
6 Drug Discovery Services Market, By Process, 2015–2022 (USD Million)

Request for call back:

[email protected]  / Call +1 888 391 5441

For further information and more details with intelligence needs for your business. Access to in-depth market trends helps companies to assess the market effectiveness.